Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Deficit (unaudited)

v3.20.2
Condensed Statements of Stockholders' Equity (Deficit (unaudited) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at beginning at Sep. 30, 2018 $ 832,013 $ 36,640,009 $ (41,858,257) $ (4,386,235)
Balance at beginning (in shares) at Sep. 30, 2018 832,013,272      
Stock based compensation   1,217,213   1,217,213
Common stock issued for cash $ 19,325 946,925   966,250
Common stock issued for cash (in shares) 19,325,000      
Warrants issued for debt extension   152,078   152,078
Warrants issued in debt transaction   5,090,470   5,090,470
Stock issued for warrant exercise $ 240,928 9,844,072   10,085,000
Stock issued for warrant exercise (in shares) 240,928,572      
Net Loss     (12,162,013) (12,162,013)
Balance at end at Jun. 30, 2019 $ 1,092,266 53,890,767 (54,020,270) 962,763
Balance at end (in shares) at Jun. 30, 2019 1,092,266,844      
Balance at beginning at Mar. 31, 2019 $ 1,089,433 52,794,028 (47,512,257) 6,371,204
Balance at beginning (in shares) at Mar. 31, 2019 1,089,433,510      
Stock based compensation   415,111   415,111
Warrants issued for debt extension   152,078   152,078
Warrants issued in debt transaction   447,383   447,383
Stock issued for warrant exercise $ 2,833 82,167   85,000
Stock issued for warrant exercise (in shares) 2,833,334      
Net Loss     (6,508,013) (6,508,013)
Balance at end at Jun. 30, 2019 $ 1,092,266 53,890,767 (54,020,270) 962,763
Balance at end (in shares) at Jun. 30, 2019 1,092,266,844      
Balance at beginning at Sep. 30, 2019 $ 1,092,266 54,160,836 (55,582,010) $ (328,908)
Balance at beginning (in shares) at Sep. 30, 2019 1,092,266,844     1,092,266,844
Cumulative adjustment upon ASC 842 adoption     16,431 $ 16,431
Stock based compensation   968,257   968,257
Common stock issued for conversion of convertible note payable and accrued interest $ 105,558 1,975,068   2,080,626
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 105,557,528      
Common stock registration costs   (15,398)   (15,398)
Stock Issued to extinguish liability $ 38,423 1,498,506   1,536,929
Stock Issued to extinguish liability (in shares) 38,423,221      
Warrants issued for debt extension   19,300   19,300
Net Loss     (3,493,396) (3,493,396)
Balance at end at Jun. 30, 2020 $ 1,236,247 58,606,569 (59,058,975) $ 783,841
Balance at end (in shares) at Jun. 30, 2020 1,236,247,593     1,236,247,593
Balance at beginning at Mar. 31, 2020 $ 1,212,337 57,988,449 (56,353,604) $ 2,847,182
Balance at beginning (in shares) at Mar. 31, 2020 1,212,337,346      
Stock based compensation   240,166   240,166
Common stock issued for conversion of convertible note payable and accrued interest $ 23,910 358,654   382,564
Common stock issued for conversion of convertible note payable and accrued interest (in shares) 23,910,247      
Warrants issued in debt transaction   19,300   19,300
Net Loss     (2,705,371) (2,705,371)
Balance at end at Jun. 30, 2020 $ 1,236,247 $ 58,606,569 $ (59,058,975) $ 783,841
Balance at end (in shares) at Jun. 30, 2020 1,236,247,593     1,236,247,593